VTRO (Vitro Biopharma) ROE % Adjusted to Book Value: 0.00% (As of Oct. 2022)

What is Vitro Biopharma ROE % Adjusted to Book Value?

Vitro Biopharma VTRO ROE % Adjusted to Book Value is 0.00% as of Oct. 2022. The stock has 6 warning signs investors should review.

Vitro Biopharma's ROE % for the quarter that ended in Oct. 2022 was -872.36%. Vitro Biopharma's PB Ratio for the quarter that ended in Oct. 2022 was N/A. Vitro Biopharma's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2022 was N/A.

Vitro Biopharma ROE % Adjusted to Book Value Related Terms

Vitro Biopharma ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma ROE % Adjusted to Book Value Chart

Vitro Biopharma Annual Data

Trend

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Oct17

Oct21

Oct22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

0.00

Vitro Biopharma Quarterly Data
	Oct00	Oct01	Oct02	Oct03	Oct04	Oct05	Oct06	Oct07	Oct08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15	Oct17	Oct21	Oct22
ROE % Adjusted to Book Value	Get a 7-Day Free Trial														0.00	0.00	0.00	0.00	0.00

VTRO vs : ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Vitro Biopharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vitro Biopharma ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vitro Biopharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Vitro Biopharma's ROE % Adjusted to Book Value falls into.

Save Embed

Vitro Biopharma ROE % Adjusted to Book Value Calculation

Vitro Biopharma's ROE % Adjusted to Book Value for the fiscal year that ended in Oct. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-218.09%	/	N/A
	=	N/A

Vitro Biopharma's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-872.36%	/	N/A
	=	N/A

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 0.00% mean?

Vitro Biopharma (VTRO) has a ROE % Adjusted to Book Value of 0.00% as of Oct. 2022. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Vitro Biopharma and its competitors.

Is Vitro Biopharma's ROE % Adjusted to Book Value too high?

Vitro Biopharma's current ROE % Adjusted to Book Value is 0.00%.

How does Vitro Biopharma's ROE % Adjusted to Book Value compare to ?

Vitro Biopharma's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Biotechnology company?

A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vitro Biopharma stock overvalued right now?

Vitro Biopharma (VTRO) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current ROE % Adjusted to Book Value is 0.00% as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Industry Healthcare Biotechnology

Comparable Companies

Address 4621 Technology Drive, Golden, CO, USA, 80403

Website http://www.vitrobiopharma.com

Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.